Resmed (RSMDF) Work In Process (2010 - 2026)

Resmed (RSMDF) has reported Work In Process for 17 consecutive years, with $2.6 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Work In Process rose 3.84% year-over-year to $2.6 million; the trailing twelve-month figure through Jun 2026 stood at $2.6 million (up 3.84% YoY), and the FY2026 full-year result was $2.6 million, up 3.84% from the prior year.
• Work In Process rose to $2.6 million in Q2 2026 per RSMDF's latest filing, from $2.0 million in the prior quarter.
• Across five years, Work In Process topped out at $5.2 million in Q3 2023 and bottomed at $968000.0 in Q4 2025.
• Historically, Work In Process has averaged $3.0 million across 5 years, with a median of $2.8 million in 2023.
• The widest YoY moves for Work In Process: up 77.67% in 2025, down 62.29% in 2025.
• Over 5 years, Work In Process stood at $3.0 million in 2022, then fell by 2.42% to $2.9 million in 2023, then dropped by 12.75% to $2.6 million in 2024, then tumbled by 62.29% to $968000.0 in 2025, then surged by 173.55% to $2.6 million in 2026.
• According to Business Quant data, Work In Process over the past three periods registered $2.6 million, $2.0 million, and $968000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.